文献速递眼底病与葡萄膜炎

阿姆斯勒方格表检测新生血管性年龄相关性黄斑变性的诊断准确性:系统综述与荟萃分析

Diagnostic Accuracy of the Amsler Grid Test for Detecting Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Ophthalmol · 2023-01-01

该系统综述与荟萃分析共纳入10项研究、1890只眼,评估阿姆斯勒方格表诊断新生血管性年龄相关性黄斑变性(AMD)的准确性。以健康对照为比较时,敏感度为67%(95%CI 51%-79%)、特异度为99%(95%CI 85%-100%);以非新生血管性AMD患者为对照时,敏感度为71%(95%CI 60%-80%)、特异度为63%(95%CI 49%-51%)。作者认为该表敏感度可能处于通常不推荐用于监测的水平,建议高危患者无论自测结果如何都应定期接受眼科检查。

要点

  • 以健康对照为比较,阿姆斯勒方格表诊断新生血管性AMD的敏感度为67%、特异度为99%。
  • 以非新生血管性AMD患者为对照,敏感度为71%、特异度为63%。
  • 作者认为其敏感度可能处于通常不推荐用于监测的水平。

核心结论

  • 阿姆斯勒方格表虽简单廉价,但其敏感度可能处于通常不推荐用于监测的水平。
  • 结合较低敏感度与仅中等特异度,作者建议高危患者无论自测结果如何都应定期接受眼科检查。

研究设计与样本

  • 系统综述与诊断准确性荟萃分析,检索12个数据库至2022年5月7日。
  • 共纳入10项研究、1890只眼,受试者平均年龄62至83岁。
  • 纳入研究分组为新生血管性AMD与健康眼或非新生血管性AMD眼,指数试验为阿姆斯勒方格表,参考标准为眼科检查。

主要发现

  • 以健康对照为比较,诊断新生血管性AMD的敏感度为67%(95%CI 51%-79%),特异度为99%(95%CI 85%-100%)。
  • 以非新生血管性AMD患者为对照,敏感度为71%(95%CI 60%-80%),特异度为63%(95%CI 49%-51%)。
  • 总体偏倚来源在各研究中均较低。

临床怎么用

  • 作者建议高危患者无论阿姆斯勒方格表自测结果如何都应定期接受眼科检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients with nonneovascular age-related macular degeneration (AMD) are encouraged to use the Amsler grid test for self-assessment to facilitate early diagnosis. The test is widely recommended, suggesting a belief that it signals worsening AMD, warranting its use in home monitoring. OBJECTIVE: To systematically review studies of the diagnostic test accuracy of the Amsler grid in the diagnosis of neovascular AMD and to perform diagnostic test accuracy meta-analyses. DATA SOURCES: A systematic literature search was conducted in 12 databases for relevant titles from database inception until May 7, 2022. STUDY SELECTION: Studies included those with groups defined as having (1) neovascular AMD and (2) either healthy eyes or eyes with nonneovascular AMD. The index test was the Amsler grid. The reference standard was ophthalmic examination. After removal of obviously irrelevant reports, 2 authors (J.B. and M.S.) independently screened the remaining references in full text for potential eligibility. Disagreements were resolved by a third author (Y.S.). DATA EXTRACTION AND SYNTHESIS: Two authors (J.B. and I.P.) independently extracted all data and evaluated quality and applicability of eligible studies using the Quality Assessment of Diagnostic Accuracy Studies 2. Disagreements were resolved by a third author (Y.S.). MAIN OUTCOMES AND MEASURES: Sensitivity and specificity of the Amsler grid for detecting neovascular AMD with comparators being either healthy control participants or patients with nonneovascular AMD. RESULTS: Of 523 records screened, 10 studies were included with a total of 1890 eyes (mean participant age ranging from 62 to 83 years). Sensitivity and specificity to diagnose neovascular AMD were 67% (95% CI, 51%-79%) and 99% (95% CI, 85%-100%), respectively, when comparators were healthy control participants and 71% (95% CI, 60%-80%) and 63% (95% CI, 49%-51%), respectively, when control participants were patients with nonneovascular AMD. Overall, potential sources of bias were low across studies. CONCLUSIONS AND RELEVANCE: Although the Amsler grid is easy and inexpensive to use for detection of metamorphopsia, its sensitivity may be at levels typically not recommended for monitoring. Coupling this lower sensitivity with only moderate specificity to identify neovascular AMD in a population at risk, these findings suggest that such patients typically should be encouraged to undergo ophthalmic examination regularly, regardless of any results of Amsler grid self-assessment.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bjerager J, Schneider M, Potapenko I, et al. Diagnostic Accuracy of the Amsler Grid Test for Detecting Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2023. PMID: 36795396. doi:10.1001/jamaophthalmol.2022.6396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。